New developments in autologous tumor cell vaccination therapy for renal cell carcinoma.

A. J. van den Eertwegh; H. M. Pinedo

doi:https://doi.org/10.1007/s11912-000-0053-5

New developments in autologous tumor cell vaccination therapy for renal cell carcinoma.

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	369-371
Number of pages	3
Journal	Current oncology reports
Volume	2
Issue number	5
DOIs	https://doi.org/10.1007/s11912-000-0053-5
Publication status	Published - Sept 2000

Access to Document

https://doi.org/10.1007/s11912-000-0053-5

Cite this

@article{1b9fa3554d4d46f3bd968a391a5413ae,

title = "New developments in autologous tumor cell vaccination therapy for renal cell carcinoma.",

author = "{van den Eertwegh}, {A. J.} and Pinedo, {H. M.}",

note = "Funding Information: 4. Medical Research Council Renal Cancer Collaborators: Interferon-alpha and survival in metastatic renal carcinoma: early results of a randomised controlled trial. Lancet 1999, 53:14–17.",

year = "2000",

month = sep,

doi = "https://doi.org/10.1007/s11912-000-0053-5",

language = "English",

volume = "2",

pages = "369--371",

journal = "Current oncology reports",

issn = "1523-3790",

publisher = "Current Science, Inc.",

number = "5",

}

TY - JOUR

T1 - New developments in autologous tumor cell vaccination therapy for renal cell carcinoma.

AU - van den Eertwegh, A. J.

AU - Pinedo, H. M.

N1 - Funding Information: 4. Medical Research Council Renal Cancer Collaborators: Interferon-alpha and survival in metastatic renal carcinoma: early results of a randomised controlled trial. Lancet 1999, 53:14–17.

PY - 2000/9

Y1 - 2000/9

UR - http://www.scopus.com/inward/record.url?scp=0034276667&partnerID=8YFLogxK

U2 - https://doi.org/10.1007/s11912-000-0053-5

DO - https://doi.org/10.1007/s11912-000-0053-5

M3 - Article

C2 - 11122867

SN - 1523-3790

VL - 2

SP - 369

EP - 371

JO - Current oncology reports

JF - Current oncology reports

IS - 5

ER -

New developments in autologous tumor cell vaccination therapy for renal cell carcinoma.

Access to Document

Other files and links

Cite this